This article reviews contemporary concepts underlying the design of control
strategies for the management of flea allergy dermatitis in dogs and cats.
The limitations of palliative symptomatic approaches are noted, as is the
Fundamental requirement to differentiate simple pulicosis from true hyperse
nsitivity. In the latter case, eradication of fleas from the affected anima
l and its surroundings has to be an essential aim. The different biological
properties offered by modern chemotherapy are defined and the range of tec
hniques for applying active compounds to the animal and its environment des
cribed. Factors for consideration when formulating control strategies and s
electing chemotherapeutic agents are discussed in the context of the comple
xities of the flea life-cycle, the host-parasite relationship and client co
ncerns.